These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14965013)

  • 1. [Vestibular disorders and methods for their correction].
    Mironenko TV
    Lik Sprava; 2003 Dec; (8):72-6. PubMed ID: 14965013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
    Popova NF; Chugunova MA; Kunel'skaia NL; Shagaev AS; Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):77-81. PubMed ID: 21916160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vestibular disorders in patients with otosclerosis: prevalence, diagnostic and therapeutic options].
    Morozova SV; Dobrotin VE; Kulakova LA; Kaspranskaia GR; Ovchinnikov IuM
    Vestn Otorinolaringol; 2009; (2):20-2. PubMed ID: 19491792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rehabilitation of patients with peripheral vestibular disorders].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2004; (2):59-61. PubMed ID: 15139364
    [No Abstract]   [Full Text] [Related]  

  • 9. Betahistine in the treatment of tinnitus in patients with vestibular disorders.
    Ganança MM; Caovilla HH; Gazzola JM; Ganança CF; Ganança FF
    Braz J Otorhinolaryngol; 2011; 77(4):499-503. PubMed ID: 21860977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of betaserk in vestibular disorders].
    Abdulkerimov KhT; Markov IS; Usachev VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(6):50-2. PubMed ID: 12101896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vestibular migraine].
    Trinus KF; Klymenko OI
    Lik Sprava; 2003; (1):82-5. PubMed ID: 12712619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation.
    Mira E
    Int J Clin Pract; 2008 Jan; 62(1):109-14. PubMed ID: 17537195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional sensitivity of the vestibular analyzer].
    Kriukov AI; Veselago OV; Tanashian MM
    Vestn Otorinolaringol; 2004; (6):9-12. PubMed ID: 15699980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rational selection of vasoactive drugs for the treatment of patients with vestibular dysfunction].
    Boĭko NV
    Vestn Otorinolaringol; 1991; (5):42-7. PubMed ID: 1755185
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of betaserk in experimental motor disease].
    Mantsev EI; Sigaleva EE
    Vestn Otorinolaringol; 2005; (6):49-52. PubMed ID: 16353011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].
    Odinak MM; Kovalenko AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):55-7. PubMed ID: 16117150
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vestibular disorders in Parkinson patients].
    Henzi S; Stanga Z; Ludin HP
    Schweiz Med Wochenschr; 1990 Sep; 120(36):1297-303. PubMed ID: 2218450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of autonomic sensory disorders in middle ear diseases].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2002; (3):38-41. PubMed ID: 12227028
    [No Abstract]   [Full Text] [Related]  

  • 19. [The characteristics of vestibular-visual interaction in patients with cochleovestibular disorders under galvanic stimulation].
    Mel'nikov OA
    Vestn Otorinolaringol; 1994; (5-6):25-8. PubMed ID: 7856015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology, clinical features and betaserc therapy of vertigo in initial and reversible cerebrovascular pathology].
    Gornostaeva GV; Varakin IuIa; Prokopovich ME; Alekseeva NS; Fedin PA; Chechetkin AO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):14-7. PubMed ID: 16250576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.